Landing
National Organization for Rare Disorders (NORD) 2023
Plain Language Poster: Human Factors Validation Study for a Wearable, Single-Use Injection Device for Pegcetacoplan
Safety and Effectiveness of Pegcetacoplan for Adults With Paroxysmal Nocturnal Hemoglobinuria: A Plain Language Summary of the First 48 Weeks of Study 307
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.